First Wave BioPharma, Inc. (FWBI)

NASDAQ: FWBI · IEX Real-Time Price · USD

2.590

-0.250 (-8.80%)

At close: Apr 19, 2024, 3:29 PM

2.580

-0.010 (-0.39%)

After-hours: Apr 19, 2024, 4:05 PM EDT

First Wave BioPharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Selling, General & Admin	10.74	11.99	18.38	7.29	6.06	7.45	7.69	4.13	3.33	1.66
Research & Development	5.03	0.69	38.32	19.14	8.68	5.77	2.4	2.5	1.4	0.67
Other Operating Expenses	0	0	2.35	0	0	0	0	0	0	0
Operating Expenses	15.77	12.68	59.06	26.43	14.74	13.22	10.08	6.63	4.73	2.33
Operating Income	-15.77	-12.68	-59.06	-26.43	-14.74	-13.22	-10.08	-6.63	-4.73	-2.33
Interest Expense / Income	0.02	0.02	0.01	5.84	0.43	0.1	0.88	5.94	1.59	0.07
Other Expense / Income	0	1.94	-0.53	0.4	-	0.21	0.14	2.03	-0.39	-0.03
Pretax Income	-15.79	-14.63	-58.54	-32.67	-15.18	-13.53	-11.1	-14.59	-5.93	-2.37
Net Income	-15.79	-14.63	-58.54	-32.67	-15.18	-13.53	-11.1	-14.59	-5.93	-2.37
Preferred Dividends	0.31	0.34	25.98	9.06	0	0	0	0	0	0
Net Income Common	-16.1	-14.97	-84.52	-41.73	-15.18	-13.53	-11.1	-14.59	-5.93	-2.37
Shares Outstanding (Basic)	0	0	0	0	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0	0	0	0	0
Shares Change	836.57%	1589.98%	213.88%	26.78%	45.11%	45.45%	63.23%	80.23%	2.38%	-
EPS (Basic)	-47.88	-416.94	-39770.60	-61656.68	-28560.31	-36960.41	-43680.48	-94081.04	-68460.75	-28140.31
EPS (Diluted)	-47.88	-416.94	-39770.60	-61656.68	-28560.31	-36960.41	-43680.48	-94081.04	-68460.75	-28140.31
Free Cash Flow	-12.38	-22.34	-32.36	-11.13	-14.06	-10.92	-7.22	-4.55	-4.19	-1.2
Free Cash Flow Per Share	-36.80	-622.19	-15226.08	-16445.22	-26328.25	-29719.32	-28517.60	-29360.73	-48572.05	-14201.09
EBITDA	-15.74	-14.58	-57.98	-26.27	-13.72	-12.63	-9.47	-7.92	-3.61	-1.87
Depreciation & Amortization	0.03	0.03	0.54	0.56	1.02	0.8	0.75	0.73	0.73	0.43
EBIT	-15.77	-14.61	-58.53	-26.83	-14.74	-13.43	-10.22	-8.65	-4.34	-2.3

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).